Lepu Medical

Academician Pan Yi and Professor Shen Bairong joined the Weiwei science and technology strategy committee

Medtronic's world's first self expanding pulmonary valve was first-class recalled

Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use

The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.

Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus

Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU

Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry

Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan

Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan

Zhang Wenhong: this wave of epidemic is a cold spring, and spring is bound to come

Xingang shares: the shareholding ratio of controlling shareholders decreased from 50.16% to 49.13%

Lepu medical: Wei Zhanjiang, deputy general manager, increased 113600 shares

Laimei pharmaceutical: 99.0654 million shares held by shareholder Qiu Yu and those acting in concert will be auctioned by the judiciary

State Affairs Office: revise and issue the negative list of market access (2021 version) before the end of the year to carry out the pilot of relaxing market access

Le Pu medical: New Coronavirus (SARS-CoV-2) antigen self testing kit was awarded CE certification by EU